SOLACI-SOCIME 2025 Has Begun!

The wait is finally over. More than a year after the last congress held in Argentina, the Latin American Society of Interventional Cardiology (SOLACI) returns to Mexico, alongside the Mexican Society of Interventional Cardiology (SOCIME), to kick off the most significant event in the specialty in the region, celebrating its 30th edition.

For 3 days of intense scientific activity—spread across 7 simultaneous rooms and interactive spaces—the most renowned leaders in interventional cardiology worldwide will gather in high-level sessions to discuss the latest advances in the field and foster the exchange of experiences and knowledge aimed at improving the quality of life of patients with cardiovascular diseases.

This edition will feature 10 live cases using cutting-edge technology—broadcast from national and international centers—as well as edited cases on coronary and structural interventions. There will also be joint international sessions with major interventional cardiology organizations from the United States and Europe, along with innovative Lunch Symposiums featuring the participation of the medical industry.

The Commercial Exhibit will host over 40 sponsoring companies and 3 Hands-On spaces, where attendees can engage in practical demonstrations and live workshops to experience firsthand the latest devices used in percutaneous procedures.

Additionally, the 15th ProEducar-SOLACI Fellows Educational Course, the traditional Pediatrics Symposium—presenting the latest updates on congenital heart disease—and the Symposium for Technicians and Nurses will take place, consolidating an inclusive and high-quality academic program.

Join us and experience the SOLACI-SOCIME 2025 Congress through our website and social media channels. We look forward to seeing you there!


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Watch Again: Pulmonary Embolism in 2025 — Risk Stratification and Novel Therapeutic Approaches

Our webinar “Pulmonary Embolism in 2025: Risk Stratification and Novel Therapeutic Approaches” is now available to watch. The session took place on November 25,...

Watch Again: SELUTION – Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives

Our webinar “SELUTION: Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives”, held on November 19, 2025 via Zoom with...

25/11 – SOLACI Webinar: Pulmonary Embolism in 2025 – Risk Stratification and Novel Therapeutic Approaches

The Latin American Society of Interventional Cardiology invites you to participate in a new virtual scientific event titled “Pulmonary Embolism (PE) in 2025: Risk...

SELUTION Sirolimus-Eluting Balloon For De Novo Coronary Lesions – New Evidence and Clinical Perspectives

The Latin American Society of Interventional Cardiology invites you to join a new virtual scientific event focused on the latest evidence and clinical perspectives...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Coronary Perforations and Use of Covered Stents: Safe and Effective Long-Term Strategy?

Coronary perforations remain one of the most serious complications of percutaneous coronary intervention (PCI), especially in cases of Ellis ruptures type III. In these...

Is it really necessary to monitor all patients after TAVR?

Conduction disorders (CD) after transcatheter aortic valve replacement (TAVR) are a frequent complication and may lead to the need for permanent pacemaker implantation (PPI)....

Is it really necessary to monitor all patients after TAVR?

Conduction disorders (CD) after transcatheter aortic valve replacement (TAVR) are a frequent complication and may lead to the need for permanent pacemaker implantation (PPI)....